1998
DOI: 10.1210/jcem.83.5.4833
|View full text |Cite
|
Sign up to set email alerts
|

Definitive Adrenal Insufficiency Due to Bilateral Adrenal Hemorrhage and Primary Antiphospholipid Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0
1

Year Published

2002
2002
2015
2015

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(17 citation statements)
references
References 17 publications
0
13
0
1
Order By: Relevance
“…Recently, several reports have pointed out the relationship of primary adrenal failure with the presence of elevated aPL levels. 2,3 With the discovery of the aCL and the delineation of the antiphospholipid syndrome (APS) in the 1980s, however, it soon became clinically obvious that the association of these antibodies with hypoadrenalism was more than fortuitous, and indeed a strong 'cause and effect' relationship between the two conditions existed.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, several reports have pointed out the relationship of primary adrenal failure with the presence of elevated aPL levels. 2,3 With the discovery of the aCL and the delineation of the antiphospholipid syndrome (APS) in the 1980s, however, it soon became clinically obvious that the association of these antibodies with hypoadrenalism was more than fortuitous, and indeed a strong 'cause and effect' relationship between the two conditions existed.…”
Section: Introductionmentioning
confidence: 99%
“…The antiphospholipid syndrome is a recognized cause of adrenal failure which can, on rare occasions, be the heralding manifestation of PAPS (6,7). In such cases, CT or MRI usually reveals bilateral adrenal hemorrhage (6,8).…”
Section: Discussionmentioning
confidence: 99%
“…Also patients suffering from the primary antiphospholipid antibody syndrome are prone to adrenal hemorrhage, which occurs usually when the patient has undergone surgery or requires anticoagulant treatment for recurrent arterial and venous thromboembolism. This syndrome is characterized by propensity to intravascular thrombosis and prolonged prothrombin time due to circulating antibodies to phospholipid; it may be primary or associated to a variety of conditions (connective tissue disorders, malignancies, after some prolonged treatments) (Caron et al 1998).…”
Section: Adrenal Hemorrhagementioning
confidence: 99%